Literature DB >> 6977583

Mechanisms of immune lysis. III. Characterization of the nature and kinetics of the cytotoxic T lymphocyte-induced nuclear lesion in the target.

J H Russell, V Masakowski, T Rucinsky, G Phillips.   

Abstract

The experiments reported here demonstrate that the event leading to CTL-induced nuclear disintegration is kinetically similar (t1/2 = 3.1 +/- 0.8 min) to that reported for CTL-induced plasma membrane disintegration as measured by 51Cr release. However, the expression of the lethal event by detergent-soluble 125I release occurs so rapidly that the time between the initiation of the lesion and its expression is 15 min instead of the 90 to 120 min time course for plasma membrane disintegration measured by 51Cr release. In addition, we have demonstrated that the rapid 125IUdR release characteristic of CTL-lysed targets is specific for the nucleus within the target cell itself. Isolated nuclei cultured with effectors and targets during a lytic reaction are not rapidly damaged by the lytic process. Finally, we have characterized the CTL-induced nuclear lesion as a degradative process occurring within the plasma membrane of the target cell. The significance of these events and their relationship to the CTL's role in the host defense system is discussed.

Mesh:

Substances:

Year:  1982        PMID: 6977583

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Ultrastructural changes during lysis of L929 target cells by class II-restricted influenza virus-specific murine cytotoxic T-lymphocyte clones.

Authors:  N Ono; K K Ko; Y Hosaka
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes.

Authors:  D S Ucker; P S Obermiller; W Eckhart; J R Apgar; N A Berger; J Meyers
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9.

Authors:  D M Lowrey; T Aebischer; K Olsen; M Lichtenheld; F Rupp; H Hengartner; E R Podack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant.

Authors:  D S Schmid; J P Tite; N H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  MHC-specific cytotoxic T lymphocyte killing of dissociated sympathetic neuronal cultures.

Authors:  P T Manning; E M Johnson; C L Wilcox; M A Palmatier; J H Russell
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

7.  Lack of lymphocyte-induced DNA fragmentation in human targets during lysis represents a species-specific difference between human and murine cells.

Authors:  J E Christiaansen; D W Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells.

Authors:  C R Knight; R C Rees; A Platts; T Johnson; M Griffin
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

10.  Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes.

Authors:  D A Bell; B Morrison; P VandenBygaart
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.